Patients with sight limiting diseases like Macular Degeneration know the importance of regular treatments to preserve existing vision.
The most common treatments to slow vision loss from wet macular degeneration are anti-VEGF intravitreal injections.
These drugs are considered the first-line treatment for all stages of wet macular degeneration and are typically scheduled every 4-6 weeks to maintain effectiveness.
That all changed in the past month with the outbreak of COVID-19.
To accommodate the situation, Florida Eye Institute quickly prioritized procedures to continue providing care for their most vulnerable patient populations.